Previous studies have shown that supplementation with probiotics can effectively improve levels of inflammatory cytokines such as TNF-α, IL-6 and IL-1β in NAFLD mouse or rat models (23, 46–51). This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.